Pathogenic FBP1 gene mutations impair FBPase activity, causing patients unable to effectively metabolize pyruvate and lactate to glucose for energy demand during fasting or infection, leading to hypoglycemia and metabolic acidosis (Emecen Sanli et al., 2022). This evidence concerns the gene FBP1 and Hypoglycemia.